FINDELL CAPITAL MANAGEMENT LLC
CIK: 0001814465Latest portfolio: $347.8M · Q4 2025
Holdings
15
Total Value
$347.8M
New Positions
4
Closed Positions
3
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 4,207,449 | $145.1M | 41.73% | -132,751 | Put |
| 2 | ESTAESTABLISHMENT LABS HLDGS INC | 1,130,460 | $82.4M | 23.69% | -164,960 | |
| 3 | ROOTROOT INC | 235,000 | $17.0M | 4.88% | +175K | |
| 4 | DAVEDAVE INC | 70,000 | $15.5M | 4.46% | +32K | |
| 5 | TPBTURNING PT BRANDS INC | 127,000 | $13.8M | 3.96% | +37K | |
| 6 | OPRTOPORTUN FINL CORP | 2,568,300 | $13.6M | 3.91% | — | |
| 7 | SGHCSUPER GROUP SGHC LIMITED | 940,000 | $11.2M | 3.23% | +270K | |
| 8 | GEGGEO GROUP INC NEW | 650,000 | $10.5M | 3.01% | +90K | |
| 9 | CELHCELSIUS HLDGS INC | 210,000 | $9.6M | 2.76% | NEW | |
| 10 | EHTHEHEALTH INC | 1,408,975 | $6.5M | 1.86% | +184K | |
| 11 | ABVXABIVAX SA | 48,000 | $6.5M | 1.86% | +8K | |
| 12 | LRNSTRIDE INC | 90,000 | $5.8M | 1.68% | NEW | |
| 13 | ADMAADMA BIOLOGICS INC | 300,000 | $5.5M | 1.57% | NEW | |
| 14 | VORVOR BIOPHARMA INC | 231,000 | $3.0M | 0.87% | NEW | |
| 15 | MLYSMINERALYS THERAPEUTICS INC | 50,000 | $1.8M | 0.52% | -200,000 |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($1.4511482387104786e+22T)
Financial Services0.0% ($16974.1T)
Consumer Defensive0.0% ($1376.7T)
Technology0.0% ($15.5M)
Consumer Cyclical0.0% ($11.2M)
Filing History
Fund Information
FINDELL CAPITAL MANAGEMENT LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $347.8M across 15 holdings. The largest position is LIQUIDIA CORPORATION (LQDA), representing 41.7% of the portfolio. Compared to the previous quarter, the fund opened 4 new positions and closed 3 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.